Decoding the Mechanism of Shixiao Powder in Treating Coronary Heart Disease Based on Network Pharmacology and Molecular Docking

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left">Classification</td><td class="align_center">ID</td><td class="align_center">Description</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left" rowspan="2">Atherosclerosis</td><td class="align_center">hsa05417</td><td class="align_center">Lipid and atherosclerosis</td></tr><tr><td class="align_center">hsa05418</td><td class="align_center">Fluid shear stress and atherosclerosis</td></tr><tr><td class="align_left" rowspan="3">Inflammatory and immune</td><td class="align_center">hsa04668</td><td class="align_center">TNF signalling pathway</td></tr><tr><td class="align_center">hsa04010</td><td class="align_center">MAPK signalling pathway</td></tr><tr><td class="align_center">hsa04657</td><td class="align_center">IL-17 signalling pathway</td></tr><tr><td class="align_left">Oxidative stress</td><td class="align_center">hsa04933</td><td class="align_center">AGE-RAGE signalling pathway in diabetic complications</td></tr><tr><td class="align_left" rowspan="2">Infection</td><td class="align_center">hsa05163</td><td class="align_center">Human cytomegalovirus infection</td></tr><tr><td class="align_center">hsa05161</td><td class="align_center">Hepatitis B</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Evidence-Based Complementary and Alternative Medicine

tab2

Table 2

Table 2: Decoding the Mechanism of Shixiao Powder in Treating Coronary Heart Disease Based on Network Pharmacology and Molecular Docking 